Udg Healthcare Plc (NASDAQ:UDHCF) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a note issued to investors on Saturday, June 10th. The brokerage presently has a $9.00 price objective on the stock. Zacks Investment Research‘s price target would suggest a potential upside of 12.36% from the company’s previous close.
According to Zacks, “UDG Healthcare plc provide services to the healthcare industry. The company’s operating segment consists of Ashfield Commercial & Medical Services, Sharp Packaging Services and Supply Chain Services. Ashfield Commercial & Medical Services division provides sales teams, healthcare communications, telesales, nurse educators, medical information, pharmacovigilance, regulatory and event management services. Sharp Packaging Service division provides contract packaging and clinical trial packaging services. Supply Chain Services provides outsourced sales, marketing, distribution and engineering services. UDG Healthcare plc operates primarily in US, UK, Ireland and Germany. UDG Healthcare plc is based in Dublin, the Republic of Ireland. “
Shares of Udg Healthcare Plc (NASDAQ UDHCF) remained flat at $8.01 during trading on Friday. Udg Healthcare Plc has a one year low of $7.45 and a one year high of $8.91. The company has a market capitalization of $1.98 billion and a price-to-earnings ratio of 9.77. The firm has a 50-day moving average of $8.01 and a 200 day moving average of $8.08.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Udg Healthcare Plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Udg Healthcare Plc and related companies with MarketBeat.com's FREE daily email newsletter.